SKI Market

Indian Indices

Sensex

82,792.45 294.31
( 0.36%)

Global Indices

Nasdaq

49,410.74 -272.93
(-0.55%)

Dow Jones

6,881.90 -20.41
(-0.30%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,620.33 -65.85
(-0.62%)

Forex

USD-INR

90.70 0.01
(0.01%)

EUR-INR

107.23 -0.14
(-0.13%)

GBP-INR

122.83 -0.27
(-0.22%)

JPY-INR

0.59 0.00
(-0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Welcure Drugs & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524661

INE331C01025

1.0860857

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

1.17

42.02

EPS(TTM)

Face Value()

Div & Yield %

0.29

Back

Gland Pharma consolidated net profit rises 27.74% in the December 2025 quarter

Jan 29,2026

Net profit of Gland Pharma rose 27.74% to Rs 261.48 crore in the quarter ended December 2025 as against Rs 204.69 crore during the previous quarter ended December 2024. Sales rose 22.49% to Rs 1695.36 crore in the quarter ended December 2025 as against Rs 1384.05 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1695.36	1384.05	22
OPM %	25.65	26.01	-
PBDT	494.12	395.63	25
PBT	386.48	299.30	29
NP	261.48	204.69	28

82,792.45 294.31 ( 0.36%)

49,410.74 -272.93 (-0.55%)

6,881.90 -20.41 (-0.30%)

56,838.27 -629.56 (-1.10%)

10,620.33 -65.85 (-0.62%)

90.70 0.01 (0.01%)

107.23 -0.14 (-0.13%)

122.83 -0.27 (-0.22%)

0.59 0.00 (-0.51%)